Relentless Pursuit Partners
VC Fund
Vancouver, Canada
Relentless Pursuit Partners is an early stage fund dedicated to investing in preventative and proactive technology solutions that optimize health, activity and longevity.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Relentless Pursuit Partners invests in
Stages Relentless Pursuit Partners invests in
Countries Relentless Pursuit Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $398k–$2.8M
- Series A
- $4.5M–$7.6M
Investment Focus
Industry
- Health Care 4 (31%)
- Machine Learning 3 (23%)
- Artificial Intelligence 3 (23%)
- Medical 2 (15%)
- Software 2 (15%)
Stage
- Seed 6 (46%)
- Series A 2 (15%)
- Pre-Seed 1 (8%)
- Funding Round 1 (8%)
Country
- Canada 5 (38%)
- United States 2 (15%)
- India 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Simon Whitfield
Co-Founder, Partner
|
Co-Founder, Partner | Total investments: 2 | Find email | |
Brenda Irwin
Managing Partner & Co-Founder
|
Managing Partner & Co-Founder | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Modality.AI
|
Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health. | $570.5K / Seed / Oct 07, 2024 | |
|
Modality.AI
|
Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health. | $1.1M / Seed / Oct 07, 2022 | |
LUCID
|
LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. | $2.3M / Seed / Aug 12, 2022 | |
|
LUCID
|
LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. | $2.5M / Pre-Seed / Aug 12, 2022 | |
ClaimBuddy
|
ClaimBuddy acts as one-stop solutions for Health Insurance Claim assistance for Patients and Hospitals. ClaimBuddy are building an ecosystem to ensure Hassle-free insurance claims by leveraging technology, and a set of simple yet powerful processes and operations. | $2.8M / Seed / Feb 28, 2022 | |
WayFr
|
WayFr is a mobile application that instantly enables shippers and freight brokers to create their personalized load-board (load posting platform) that they can use to receive price quotes and book trucks within their network of carriers. Brokers and Shippers can additionally leverage WayFr registered carrier networks and social media groups to findtrucks from outside of their own network. | $397.8K / Seed / Dec 07, 2021 | |
|
Modality.AI
|
Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health. | $1.7M / Seed / Jul 30, 2021 | |
Orpyx
|
Orpyx Medical Technologies empowers people with diabetes to maintain mobility. The company’s core product line, the Orpyx SI sensory insoles with remote patient monitoring, helps manage and prevent diabetic foot ulcers and limb loss through advanced foot sensor technology and real-time analytics. Orpyx technology is also used by researchers toaccess clinical-grade plantar pressure data for health and human performance applications in the fields of sports medicine, therapeutic applications, and footwear design. Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention-focused and sustainable in cost. Orpyx Medical Technologies was founded in 2010 and is headquartered in Calgary, Alberta, Canada. | $7.6M / Series A / Jul 08, 2020 | |
ePACT Network
|
ePACT will improve emergency preparedness across North America. By connecting every home and organization with shared information and resources, ePACT will have a positive impact on the safety of our communities. Its benefits will encourage users to adopt and share the system, while its tools help North Americans manage unexpected situations. | $4.5M / Series A / Aug 30, 2019 | |
Canary Medical
|
BioScience Managers Commits AUS$10M to New joint venture with Canary medical to serve as a platform to collect and monetize data from implantable and wearable medical devices.Vancouver, British Columbia, Aug 1, 2017 – Canary Medical (Canary) is pleased to announce the formation of CHARM Informatics Pty Ltd (CHARM), in collaboration with BioScienceManagers Pty Ltd (BioScience) of Melbourne, Australia. | May 18, 2018 | |
| See all 13 investments → | |||
Co-Investors
Novalis Biotechnology Incubation
3 deals together
Threshold Impact
3 deals together
BioScience Managers Limited
2 deals together
GF Securities
2 deals together
Leva Capital
2 deals together
Amplify Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Relentless Pursuit Partners invest in?
Relentless Pursuit Partners invests primarily in Health Care, Machine Learning and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 13 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Relentless Pursuit Partners's check size?
Relentless Pursuit Partners typically joins rounds of $398k–$2.8M at Seed and $4.5M–$7.6M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Relentless Pursuit Partners participates in.
How do I contact Relentless Pursuit Partners?
Public channels for Relentless Pursuit Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Relentless Pursuit Partners?
The team at Relentless Pursuit Partners includes Simon Whitfield (Co-Founder, Partner) and Brenda Irwin (Managing Partner & Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
